Podcast: Play in new window | Download (Duration: 5:50 — 4.0MB) | Embed
Subscribe: Apple Podcasts | Spotify | iHeartRadio | Email | TuneIn | RSS | More
Donna LaVoie, founder and CEO of LaVoie Health Sciences, a strategic communications firm joins Enterprise Radio to talk about the health science arena. Donna has over 20 years in business strategy, corporate communications, public and investor relations.
Listen to interview with host Eric Dye & guest Donna LaVoie discuss the following:
- What is LaVoie Group and what services do you provide your customers?
- What differentiates your firm from others?
- Why are you focused in the health sciences area?
- Why do your clients choose LaVoie Group?
- How does or how would a client know when they need a strategic communications firm?
- What have you learned over the 12 years in running a successful firm that would help other entrepreneurs?
Duration: 5:50
Donna has over 20 years in business strategy, corporate communications, public and investor relations. Since starting the agency in 2001, Donna’s efforts combine building the agency’s pharmaceutical and life science practices, strategic direction and core competencies. Under Donna’s leadership, LaVoie Group has become the acknowledged leader in life science and pharmaceutical communications and recognized as a top 25 independent healthcare agencies in the US. For the past four years, LaVoie Group has been recognized by the League of American Communications Professionals for agency awards. Over the last three years, the firm has received 16+ prestigious PR and marketing awards for their efforts on behalf of their clients.
Donna’s focus is in helping clients build their companies and brands during transformational times. Her approach centers on bringing a credible voice with key audiences while providing strategic counsel that builds value. She brings knowledge of all aspects of the corporate marketing effort and the integration of strategic options to the overall mix. One of her core strengths is the development of strong relationships among industry, venture, and investor communities and media.
Prior to leading LaVoie Group as President and CEO, Donna was a communications and investor relations practitioner, having spent her career in senior communications and investor relations roles at leading biopharmaceutical and technology firms.
Donna held the position of Vice President, Corporate and Strategic Marketing at Stream International (now Solectron), Vice President of Investor Relations at Cambridge Technology Partners (now Novell, Inc.), and senior communications and investor relations roles at several life sciences companies including Ergo Science Corporation, Alkermes, Inc., and Genzyme Corporation, where she led the company’s corporate communications and public relations efforts.
She is a frequent speaker and has been published on a variety of subjects including integrated and crisis communications, investor and public relations best practices. She holds a Bachelor of Science in Management from Lesley College and has completed a strategic marketing program at The Wharton School. Donna is also a member of the Senior Roundtable at the National Investor Relations Institute, is a part co-Chair of MassBio’s communications and marketing committee and currently serves Advamed’s host and welcome committee for the 2013 conference.
Links: www.lavoiegroup.com
